135 related articles for article (PubMed ID: 33478872)
21. [A case of congenital hepatic fibrosis diagnosed and treated by transjugular intrahepatic portosystemic shunt].
Wang J; Shu J; Wu F; Song ZT; Gan HY; Yu J; Zheng D
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):373-376. PubMed ID: 33979966
[TBL] [Abstract][Full Text] [Related]
22. [Transjugular intrahepatic portosystemic shunt with Viatorr stent grafting: report of 3 cases].
Zhao JB; Ye P; Zeng QL; Pang HJ; He XF; Chen Y
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):294-6. PubMed ID: 26922035
[TBL] [Abstract][Full Text] [Related]
23. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
Olliff SP
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
[TBL] [Abstract][Full Text] [Related]
24. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis.
Rodrigues SG; Sixt S; Abraldes JG; De Gottardi A; Klinger C; Bosch J; Baumgartner I; Berzigotti A
Aliment Pharmacol Ther; 2019 Jan; 49(1):20-30. PubMed ID: 30450634
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
[TBL] [Abstract][Full Text] [Related]
26. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
27. [Hemolytic anemia secondary to the placement of a portosystemic stented shunt].
Carrillo-Esper R; Carrillo-Cortes U; Carrillo-Córdova JR; Carrillo-Córdova LD; Carrillo-Córdova CA; Carrillo-Córdova DM
Cir Cir; 2013; 81(2):143-7. PubMed ID: 23522316
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of influencing factors of shunt dysfunction after transjugular intrahepatic portosystemic shunt in liver cirrhosis accompanied with portal vein thrombosis].
Li X; Wang HL; Zhou TY; Chen SQ; Nie CH; Zhang YL; Yu ZN; Zhou GH; Zhu TY; Sun JH
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):742-746. PubMed ID: 33053973
[No Abstract] [Full Text] [Related]
29. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt.
Therapondos G; Wong F
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1161-6. PubMed ID: 17033435
[TBL] [Abstract][Full Text] [Related]
30. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D
Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660
[TBL] [Abstract][Full Text] [Related]
31. Transjugular intrahepatic portosystemic shunt for a wait list patient is not a contraindication for orthotopic liver transplant outcomes.
Levi Sandri GB; Lai Q; Lucatelli P; Melandro F; Guglielmo N; Mennini G; Berloco PB; Fanelli F; Salvatori FM; Rossi M
Exp Clin Transplant; 2013 Oct; 11(5):426-8. PubMed ID: 23745783
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
[TBL] [Abstract][Full Text] [Related]
33. Detachable balloon-modified reducing stent to treat hepatic insufficiency after transjugular intrahepatic portosystemic shunt creation.
Kaufman L; Itkin M; Furth EE; Stewart C; Trerotola SO
J Vasc Interv Radiol; 2003 May; 14(5):635-8. PubMed ID: 12761318
[TBL] [Abstract][Full Text] [Related]
34. Minilaparotomy-assisted transmesenteric approach for portal vein recanalization and transjugular intrahepatic portosystemic shunt in a non-cirrhotic patient with portal cavernoma.
David A; Metairie S; Perret C; Schnee M; Archambeaud I; Frampas E; Douane F
Diagn Interv Imaging; 2020 Jun; 101(6):417-419. PubMed ID: 31899148
[No Abstract] [Full Text] [Related]
35. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation.
Senzolo M; Tibbals J; Cholongitas E; Triantos CK; Burroughs AK; Patch D
Aliment Pharmacol Ther; 2006 Mar; 23(6):767-75. PubMed ID: 16556179
[TBL] [Abstract][Full Text] [Related]
36. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis.
Song T; Rössle M; He F; Liu F; Guo X; Qi X
Dig Liver Dis; 2018 Apr; 50(4):323-330. PubMed ID: 29422242
[TBL] [Abstract][Full Text] [Related]
37. Transjugular intrahepatic portosystemic stent shunt placement and embolization for hemorrhage associated with rupture of anorectal varices.
Wu X; Xuan W; Song L
J Int Med Res; 2018 Apr; 46(4):1666-1671. PubMed ID: 29338471
[TBL] [Abstract][Full Text] [Related]
38. Congenital Portosystemic Shunts: Clinical Presentations, Imaging, Case Selection, and Feasibility of Transcatheter Closure.
Karmegaraj B; Kappanayil M; Rajeshkannan R; Koneti NR; Kumar RK
JACC Cardiovasc Imaging; 2021 Dec; 14(12):2470-2476. PubMed ID: 33248961
[No Abstract] [Full Text] [Related]
39. [Transcutaneous intrahepatic portosystemic shunting as a method of treatment of decompensated portal hypertension].
Furkalo SN; Kondratiuk VA
Klin Khir; 2003 Feb; (2):56-9. PubMed ID: 12784439
[No Abstract] [Full Text] [Related]
40. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.
Krieger S; Jauss M; Jansen O; Stiehl A; Sauer P; Geissler M; Theilmann L; Krieger D
J Hepatol; 1997 Jul; 27(1):121-6. PubMed ID: 9252084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
